Chain offering loyalty points for healthy choicesWalgreen's program intended to influence behaviors associated with long-term problems or chronic disease. Newfoundland and Labrador expands med review programProvince also introduces new adherence service for patients with COPD. Hypertension and some antihypertensive meds linked to higher psoriasis risk What your patients are reading – Week of July 7, 2014 Inspra now approved for treatment of mild–moderate hypertension Formerly indicated only in patients with heart failure. Managing hypertensive disorders during pregnancy New Canadian guidelines outline diagnosis, evaluation and treatment. Improving quality of life for the frail and elderly A new program has tools we can use to tailor our care to individuals Antihypertensives and serious fall injuries in the elderly Hypertension occurs in most patients receiving VEGF inhibitor therapy for cancer Guidelines needed to improve hypertension management without affecting cancer response. Invokana: first sodium-glucose co-transporter 2 inhibitor for type 2 diabetes Reduces plasma glucose by decreasing renal reabsorption and increasing urinary excretion of glucose. First Previous 45 46 47 48 49 Next Last
